Fasudil

DB08162InvestigationalSmall molecule

Fasudil has been investigated in Carotid Stenosis.

Mechanism: Pharmacologically active on Rho-associated protein kinase 1
Curator reviewed
Formula / weight: C₁₄H₁₇N₃O₂S · 291.369 g/mol (avg)
Code names: AT-877 · HA-1077 · ZK-258594

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyNGOGFTYYXHNFQH-UHFFFAOYSA-NSMILESO=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2

Targets

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

498Drug interactionsStructured to mechanism, not free text

18Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 15 drug categories

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fasudil, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.